Scarica l'app Stockscreener
55.76
2.35%
1.28
Dopo l'orario di chiusura:
55.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Royalty Pharma Secures New $1.8 Billion Credit Facility - The Globe and Mail
Royalty Pharma signs $500M co-development agreement with J&J - MSN
Royalty Pharma stock hits 52-week high at 54.82 USD By Investing.com - Investing.com Nigeria
Royalty Pharma stock hits 52-week high at 54.82 USD - Investing.com
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX - MarketBeat
Legal & General Group Plc Has $119.32 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma EVP & CFO Coyne sells $3.48 million in shares - Investing.com Canada
Royalty Pharma (RPRX) CFO-linked entity sells 64,399 shares under 10b5-1 plan - Stock Titan
Royalty Pharma plc Enters into Revolving Credit Agreement - marketscreener.com
Royalty Pharma (NASDAQ: RPRX) renews $1.8B unsecured revolver to 2031 - Stock Titan
Royalty Pharma Plc Hits New 52-Week High of $54.74 - Markets Mojo
Royalty Pharma Plc Hits New 52-Week High at $54.63 - Markets Mojo
Affiliates file to sell RPRX shares amid recent tranche sales (NASDAQ: RPRX) - Stock Titan
10% Of This Royalty Pharma Insider's Holdings Were Sold - 富途牛牛
Responsive Playbooks and the RPRX Inflection - Stock Traders Daily
HighTower Advisors LLC Grows Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Valuation Check After Strong Share Price Momentum And Royalty Growth Potential - Yahoo Finance
Royalty Pharma plc (RPRX) Stock Analysis: Exploring Its 8.72% Upside and Strategic Biopharma Investments - DirectorsTalk Interviews
Royalty Pharma Plc Hits New 52-Week High of USD 53.59 - Markets Mojo
Cumberland Partners Ltd Buys Shares of 35,000 Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma stock hits 52-week high at 53.48 USD By Investing.com - Investing.com Australia
Royalty Pharma EVP Marshall Urist sells $721,837 in shares By Investing.com - Investing.com India
Royalty Pharma PLC $RPRX Shares Bought by Handelsbanken Fonder AB - MarketBeat
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells 13,684 Shares of Stock - MarketBeat
Royalty Pharma EVP Marshall Urist sells $721,837 in shares - Investing.com
Royalty Pharma (RPRX) EVP Urist sells 13,684 shares in 10b5-1 planned trade - Stock Titan
Royalty Pharma (NASDAQ:RPRX) Hits New 12-Month HighWhat's Next? - MarketBeat
Royalty Pharma stock hits 52-week high at 53.48 USD - Investing.com
Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $4.92 Million in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ: RPRX) Rule 144 notice for 13,684-share resale - Stock Titan
ROYAL LONDON ASSET MANAGEMENT LTD's Royalty Pharma PLC(RPRX) Holding History - GuruFocus
Thrivent Financial for Lutherans Acquires 22,015 Shares of Royalty Pharma PLC $RPRX - MarketBeat
49,855 Shares in Royalty Pharma PLC $RPRX Acquired by Partners Group Holding AG - MarketBeat
Marathon Asset Management Ltd Has $15 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Acquired by Cullen Frost Bankers Inc. - MarketBeat
RPRX: Royalty financing is rapidly growing, with flexible deals and global expansion fueling future growth - TradingView
Introduction to Initial Public Offering (IPO) - Moomoo
Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance - Insider Monkey
Royalty Pharma plc (RPRX) Investor Outlook: Strong Buy Ratings and Solid Growth Prospects - DirectorsTalk Interviews
Qsemble Capital Management LP Invests $2.88 Million in Royalty Pharma PLC $RPRX - MarketBeat
Commerzbank Aktiengesellschaft FI Invests $982,000 in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead - Seeking Alpha
Royalty Pharma EVP Urist sells $726,137 in shares - Investing.com UK
Royalty Pharma EVP Urist sells $726,137 in shares By Investing.com - Investing.com Nigeria
Royalty Pharma (RPRX) EVP sells 13,684 shares under 10b5-1 plan - Stock Titan
Rule 10b5-1 sale by Royalty Pharma (RPRX) director Gregory Norden - Stock Titan
Understanding the Setup: (RPRX) and Scalable Risk - Stock Traders Daily
Press Release: Royalty Pharma Declares Second Quarter 2026 Dividend - Moomoo
Royalty Pharma (NASDAQ: RPRX) insider sale notice — 3,045 shares - Stock Titan
[144] Royalty Pharma plc SEC Filing - Stock Titan
2.69%
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):